CELLDEX THERAPEUTICS INC CLDX

US Materials In Vitro & In Vivo Diagnostic Substances
$38.37
+4.3%
52w: $20.01 – $38.37

Latest 13F among current holders filed 10 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
20.0129.1938.37
Jun 20, 2025 Jul 2, 2026
Institutional holders
229
+42 QoQ
13F value
$2.31B
+16.1% QoQ
Smart-money holders
29
signal tier ≥ 2
New smart buyers
6
Q1 2026
Options barometer
0.5×
$3.1M calls / $6.0M puts

Institutional value by quarter

$2.97B
Q1 2024
$2.58B
Q2 2024
$2.44B
Q3 2024
$1.86B
Q4 2024
$1.34B
Q1 2025
$1.47B
Q2 2025
$1.83B
Q3 2025
$1.99B
Q4 2025
$2.31B
Q1 2026

Number of holders

199
Q1 2024
184
Q2 2024
178
Q3 2024
176
Q4 2024
173
Q1 2025
183
Q2 2025
185
Q3 2025
187
Q4 2025
229
Q1 2026

Who owns CLDX?

Q1 2026 filings
FundTypeSharesValue% of fundChange
WELLINGTON MANAGEMENT GROUP LLP Long only active8.6M$271.5M0.1%+6.0%
Kynam Capital Management, LP ★3Fundamental concentrated5.8M$185.3M11.8%-1.7%
BlackRock, Inc. Index provider5.4M$170.3M0.0%-1.5%
FMR LLC Long only active3.7M$118.9M0.0%-23.6%
Point72 Asset Management, L.P. Multistrat pod3.2M$102.5M0.2%+83.7%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical3.0M$93.9M0.0%
STATE STREET CORP Index provider2.8M$88.9M0.0%-17.5%
Commodore Capital LP ★3Fundamental concentrated2.7M$85.5M4.9%+5.1%
PRICE T ROWE ASSOCIATES INC /MD/ Diversified mechanical2.1M$66.2M0.0%+2.3%
Eversept Partners, LP ★2Fundamental diversified1.8M$56.7M3.7%+24.6%
GEODE CAPITAL MANAGEMENT, LLC Index provider1.7M$53.6M0.0%+3.7%
BRAIDWELL LP ★2Fundamental diversified1.4M$43.0M1.6%-27.0%
Deep Track Capital, LP ★2Fundamental diversified1.3M$40.7M0.8%-32.4%
MILLENNIUM MANAGEMENT LLC Multistrat pod1.3M$39.8M0.0%+3.4%
Vestal Point Capital, LP ★2Fundamental diversified1.2M$38.8M1.1%+5.1%
NOVO HOLDINGS A/S ★3Fundamental concentrated1.2M$38.1M3.1%Held
Bellevue Group AG ★2Fundamental diversified1.2M$38.1M0.9%-66.8%
DIMENSIONAL FUND ADVISORS LP Quant stat arb1.1M$33.6M0.0%+62.6%
EVENTIDE ASSET MANAGEMENT, LLC Other1.0M$32.9M0.5%-36.9%
Fisher Asset Management, LLC Long only active1.0M$32.2M0.0%+8.2%
GOLDMAN SACHS GROUP INC Bank broker988.4K$31.4M0.0%-7.5%
Pictet Asset Management Holding SA Diversified mechanical923.7K$29.3M0.0%-4.6%
Elmind Capital, LP ★3Fundamental concentrated865.0K$27.4M7.8%Held
AMERICAN CENTURY COMPANIES INC Diversified mechanical856.3K$27.2M0.0%+0.1%
BANK OF AMERICA CORP /DE/ Bank broker708.6K$22.5M0.0%+70.8%
BAKER BROS. ADVISORS LP ★2Fundamental diversified665.4K$21.1M0.1%Held
Rock Springs Capital Management LP ★2Fundamental diversified650.3K$20.6M1.2%-6.1%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical629.3K$20.0M0.0%
NORTHERN TRUST CORP Index provider577.3K$18.3M0.0%+5.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider545.5K$17.3M0.0%-1.0%
STEMPOINT CAPITAL LP ★2Fundamental concentrated508.5K$16.1M1.6%New
Woodline Partners LP Other500.1K$15.9M0.1%Held
Affinity Asset Advisors, LLC ★2Fundamental diversified500.0K$15.9M0.9%+42.9%
5AM Venture Management, LLC ★3Fundamental concentrated497.3K$15.8M4.4%Held
Ikarian Capital, LLC ★2Fundamental diversified461.2K$14.6M2.1%New
Logos Global Management LP ★2Fundamental concentrated450.0K$14.3M0.7%+28.6%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical429.6K$13.6M0.0%
ADAR1 Capital Management, LLC Other427.8K$13.6M0.8%-33.9%
KENNEDY CAPITAL MANAGEMENT LLC Other352.3K$11.2M0.2%New
SEGALL BRYANT & HAMILL, LLC Other346.9K$11.0M0.2%-32.6%
Rosalind Advisors, Inc. ★2Fundamental concentrated330.0K$10.5M4.3%New
PFM Health Sciences, LP ★2Fundamental diversified325.0K$10.3M1.1%+144.0%
Foresite Capital Management VI LLC ★2Fundamental concentrated315.9K$10.0M2.2%New
Tetragon Partners GP Ltd ★3Fundamental concentrated312.3K$9.9M1.9%+28.1%
UBS Group AG Bank broker297.0K$9.4M0.0%-9.0%
Palo Alto Investors LP ★3Fundamental concentrated296.4K$9.4M1.4%New
Candriam S.C.A. Other278.9K$8.8M0.0%New
Redmile Group, LLC ★3Fundamental concentrated261.5K$8.3M0.5%-7.7%
SPHERA FUNDS MANAGEMENT LTD. Other243.6K$7.7M1.3%+1.6%
SummitTX Capital, L.P. Quant stat arb236.6K$7.5M0.2%+446.2%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.